Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort)
Guisado-Vasco, Pablo, Valderas-Ortega, Sofia, Carralón-González, Maria Maravillas, Roda-Santacruz, Ana, González-Cortijo, Lucia, Sotres-Fernández, Gabriel, Martí-Ballesteros, Eva María, Luque-Pinilla, José Manuel, Almagro-Casado, Elena, La Coma-Lanuza, Félix J., Barrena-Puertas, Ruth, Malo-Benages, Esteban Javier, Monforte-Gómez, María José, Diez-Munar, Rocío, Merino-Lanza, Esther, Comeche-Casanova, Lorena, Remirez-de-Esparza-Otero, Margarita, Correyero-Plaza, María, Recio-Rodríguez, Manuel, Rodríguez-López, Margarita, Sánchez-Manzano, María Dolores, Andreu-Vázquez, Cristina, Thuissard-Vasallo, Israel John, María-Tomé, José María Echave-Sustaeta, Carnevali-Ruiz, Daniel
Published in EClinicalMedicine (01.11.2020)
Published in EClinicalMedicine (01.11.2020)
Get full text
Journal Article
Web Resource